ARTICLE | Company News
Biogen files for Amevive approval
August 7, 2001 7:00 AM UTC
BGEN filed for FDA and EMEA approval of its Amevive alefacept ( LFA-3/IgG) recombinant human LFA-3 fusion protein that binds CD2 to treat moderate to severe chronic plaque psoriasis. ...